The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data
Open accessAbstract
OBJECTIVE: To examine risk of malignancy and death in patients with kidney transplant who receive the immunosuppressive drug sirolimus. DESIGN: Systematic review and meta-analysis of individual patient data. DATA SOURCES: Medline, Embase, and the Cochrane Central Register of Controlled Trials from inception to March 2013. ELIGIBILITY: Randomized controlled trials comparing immunosuppressive regimens with and without sirolimus in recipients of kidney or combined pancreatic and renal transplant for which the author was willing to provide individual patient level data. Two reviewers independently screened titles/abstracts and full text reports of potentially eligible trials to identify studies for inclusion. All eligible trials reported data on malignancy or survival. RESULTS: The search yielded 2365 unique citations. Patient level data were available from 5876 patients from 21 randomized trials. Sirolimus was associated with a 40% reduction in the risk of malignancy (adjusted hazard ratio 0.60, 95% confidence interval 0.39 to 0.93) and a 56% reduction in the risk of non-melanoma skin cancer (0.44, 0.30 to 0.63) compared with controls. The most pronounced effect was seen in patients who converted to sirolimus from an established immunosuppressive regimen, resulting in a reduction in risk of malignancy (0.34, 0.28 to 0.41), non-melanoma skin cancer (0.32, 0.24 to 0.42), and other cancers (0.52, 0.38 to 0.69). Sirolimus was associated with an increased risk of death (1.43, 1.21 to 1.71) compared with controls. CONCLUSIONS: Sirolimus was associated with a reduction in the risk of malignancy and non-melanoma skin cancer in transplant recipients. The benefit was most pronounced in patients who converted from an established immunosuppressive regimen to sirolimus. Given the risk of mortality, however, the use of this drug does not seem warranted for most patients with kidney transplant. Further research is needed to determine if different populations, such as those at high risk of cancer, might benefit from sirolimus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Self-citationA study of the quality of life and cost-utility of renal transplantation
Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C., & Muirhead, N. (1996) · Kidney International · doi:10.1038/ki.1996.307 · Cited by 1,167
Cancer Incidence Before and After Kidney Transplantation
Vajdic, C. M., McDonald, S. P., McCredie, M. R. E., van Leeuwen, M. T., Stewart, J. H., Law, M., Chapman, J. R., Webster, A. C., Kaldor, J. M., & Grulich, A. E. (2006) · JAMA · doi:10.1001/jama.296.23.2823 · Cited by 1,130
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
Groth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
Calculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710
Kauffman, H. M., Cherikh, W. S., Cheng, Y., Hanto, D. W., & Kahan, B. D. (2005) · Transplantation · doi:10.1097/01.tp.0000184006.43152.8d · Cited by 621
MacDonald, A. S. (2001) · Transplantation · doi:10.1097/00007890-200101270-00019 · Cited by 621
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Euvrard, S., Morelon, E., Rostaing, L., Goffin, E., Brocard, A., Tromme, I., Broeders, N., del Marmol, V., Chatelet, V., Dompmartin, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204166 · Cited by 593
Schena, F. P., Pascoe, M. D., Alberu, J., del Carmen Rial, M., Oberbauer, R., Brennan, D. C., Campistol, J. M., Racusen, L., Polinsky, M. S., Goldberg-Alberts, R., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181927a41 · Cited by 583
Kreis, H., Cisterne, J.-M., Land, W., Wramner, L., Squifflet, J.-P., Abramowicz, D., Campistol, J. M., Morales, J.-M., Grinyo, J.-M., Mourad, G., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00009 · Cited by 536
Krynitz, B., Edgren, G., Lindelöf, B., Baecklund, E., Brattström, C., Wilczek, H., & Smedby, K. E. (2013) · International Journal of Cancer · doi:10.1002/ijc.27765 · Cited by 376
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
Johnston, O., Rose, C. L., Webster, A. C., & Gill, J. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111202 · Cited by 359
Webster, A. C., Lee, V. W. S., Chapman, J. R., & Craig, J. C. (2006) · Transplantation · doi:10.1097/01.tp.0000219703.39149.85 · Cited by 335
Including Non‐Randomized Studies
Reeves, B. C., Deeks, J. J., Higgins, J. P., & Wells, G. A. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch13 · Cited by 288
Kahan, B. D., Julian, B. A., Pescovitz, M. D., Vanrenterghem, Y., & Neylan, J. (1999) · Transplantation · doi:10.1097/00007890-199911270-00016 · Cited by 279
Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation
Kaplan, B., & Meier-Kriesche, H.-U. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.21015.x · Cited by 277
Salgo, R., Gossmann, J., Schöfer, H., Kachel, H. G., Kuck, J., Geiger, H., Kaufmann, R., & Scheuermann, E. H. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02997.x · Cited by 223
Self-citationCampbell, S. B., Walker, R., Tai, S. S., Jiang, Q., & Russ, G. R. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04004.x · Cited by 221
Australia and New Zealand Dialysis and Transplant Registry
McDonald, S. P. (2015) · Kidney International Supplements · doi:10.1038/kisup.2015.8 · Cited by 219
Flechner, S. M., Glyda, M., Cockfield, S., Grinyó, J., Legendre, C., Russ, G., Steinberg, S., Wissing, K. M., & Tai, S. S. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03573.x · Cited by 217
Vincenti, F., Tedesco Silva, H., Busque, S., O’Connell, P., Friedewald, J., Cibrik, D., Budde, K., Yoshida, A., Cohney, S., Weimar, W., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04127.x · Cited by 168
Self-citationMammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients
Kasiske, B. L., de Mattos, A., Flechner, S. M., Gallon, L., Meier-Kriesche, H.-U., Weir, M. R., & Wilkinson, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02272.x · Cited by 163
Self-citationmToR inhibitors-induced proteinuria: mechanisms, significance, and management
Letavernier, E., & Legendre, C. M. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.12.001 · Cited by 141
Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney Transplantation
Sharif, A., Shabir, S., Chand, S., Cockwell, P., Ball, S. T., & Borrows, R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111160 · Cited by 136
Watson, C. J. E., Firth, J., Williams, P. F., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01055.x · Cited by 128
Self-citationReduced exposure to calcineurin inhibitors in renal transplantation.
van den Hoogen, M., & Hilbrands, L. (2008) · PubMed · Cited by 125
Guba, M. O., Pratschke, J., Hugo, C., Krämer, B. K., Nohr-Westphal, C., Brockmann, J. G., Andrassy, J., Reinke, P., Pressmar, K., Hakenberg, O. W., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e11798 · Cited by 102
Self-citationVitko, S., Włodarczyk, Z., Kyllönen, L., Czajkowski, Z., Margreiter, R., Bäckman, L., Perner, F., Rigotti, P., Jaques, B. C., Abramowicz, D., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01193.x · Cited by 94
Self-citationCampistol, J. M., Albanell, J., Arns, W., Boletis, I., Dantal, J., de Fijter, J. W., Mortensen, S., Neumayer, H. ‐., Øyen, O. M., Pascual, J., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm090 · Cited by 76
Gallon, L. G., Perico, N., Dimitrov, B. D., Dimitrov, J., Remuzzi, G., Leventhal, J. R., Gaspari, F., & Kaufman, D. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01340.x · Cited by 74
Self-citationInhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation
Isakova, T., Xie, H.-T., Messinger, S., Cortazar, F. B., Scialla, J. J., Guerra, G., Contreras, G. N., Roth, D., Burke, G. W., Molnar, M. Z., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04281.x · Cited by 63
Mackenzie, K. A., Wells, J. E., Lynn, K. L., Simcock, J., Robinson, B. A., Roake, J., & Currie, M. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp482 · Cited by 63
Glotz, D., Charpentier, B., Abramowicz, D., Lang, P., Rostaing, L. P. E., Rifle, G., Vanrenterghem, Y. F. C., Berthoux, F. C., Bourbigot, B., Delahousse, M., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181db09e4 · Cited by 62
Self-citationReduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Krishnamurthi, V. (2008) · Yearbook of Urology · doi:10.1016/s0084-4071(08)79102-4 · Cited by 59
Krämer, B. K., Klinger, M., Vitko, S., Głyda, M., Midtvedt, K., Stefoni, S., Citterio, F., Pietruck, F., Squifflet, J., Segoloni, G., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e31825c1d6c · Cited by 57
Self-citationZavos, G., Karidis, N. P., Tsourouflis, G. S., Bokos, J., Diles, K., Sotirchos, G., Theodoropoulou, E., & Kostakis, A. I. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.04939.x · Cited by 55
Oncologic Issues and Kidney Transplantation: A Review of Frequency, Mortality, and Screening
Asch, W. S., & BIA, M. J. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.07.003 · Cited by 49
Khokhar, N. Z., Altman, J. K., & Platanias, L. C. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834b892d · Cited by 46
Gelens, M. A. C. J., Christiaans, M. H. L., van Heurn, E. L. W., van den Berg-Loonen, E. M., Peutz‐Kootstra, C. J., & van Hooff, J. P. (2006) · Transplantation · doi:10.1097/01.tp.0000232688.76018.19 · Cited by 42
Self-citationCortazar, F. B., Molnar, M. Z., Isakova, T., Czira, M. E., Kovesdy, C. P., Roth, D., Mucsi, I., & Wolf, M. S. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03826.x · Cited by 40
Machado, P. G. P., Felipe, C. R., Hanzawa, N. M., Park, S. I., Garcia, R., Alfieri, F., de Franco, M. F., Junior, H. T. S., & Pestana, J. O. M. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00113.x · Cited by 31
Self-citationSirolimus for secondary SCC prevention in renal transplantation
Halleck, F., & Budde, K. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.216 · Cited by 10
Cited by
Neuberger, J. M., Bechstein, W. O., Kuypers, D. R. J., Burra, P., Citterio, F., De Geest, S., Duvoux, C., Jardine, A. G., Kamar, N., Krämer, B. K., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001651 · Cited by 315
Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews
Drucker, A. M., Fleming, P., & Chan, A.-W. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.021 · Cited by 314
Charlton, M., Levitsky, J., Aqel, B., O'Grady, J., Hemibach, J., Rinella, M., Fung, J., Ghabril, M., Thomason, R., Burra, P., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002147 · Cited by 310
EASL Clinical Practice Guidelines on liver transplantation
Samuel, D., De Martin, E., Berg, T., Berenguer, M., Burra, P., Fondevila, C., Heimbach, J. K., Pageaux, G.-P., Sanchez-Fueyo, A., & Toso, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.032 · Cited by 263
Cancer in kidney transplant recipients
Au, E., Wong, G., & Chapman, J. R. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0022-6 · Cited by 262
Metadata
- Authors
- Knoll, G. A., Kokolo, M. B., Mallick, R., Beck, A., Buenaventura, C. D., Ducharme, R., Barsoum, R., Bernasconi, C., Blydt-Hansen, T. D., Ekberg, H., Felipe, C. R., Firth, J., Gallon, L., Gelens, M., Glotz, D., Gossmann, J., Guba, M., Morsy, A. A., Salgo, R., Scheuermann, E. H., Tedesco-Silva, H., Vitko, S., Watson, C., & Fergusson, D. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-11-24
- Volume
- 349
- Issue
- nov24 1
- Pages
- g6679-g6679
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2137960096
- Cited by
- 334
- References
- 45
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.